Home » Newsletters » BioWorld Science

BioWorld Science

July 20, 2001

View Archived Issues

New erectile dysfunction therapy now available in U.K.

Mechanism of action of Mylotarg in AML elucidated

Millennium continues momentum during Q2 2001

Decitabine holds potential for chemotherapy of resistant ovarian and colon cancer

Vertex completes acquisition of Aurora Biosciences

F-13714: a high-efficacy 5-HT1A receptor agonist with potent antidepressant-like effects

Profile of a third-generation dihydropyridine-type calcium channel blocker

Tracleer NDA to be reviewed by FDA advisory committee next month

Hybrid compounds designed to have enhanced minor groove binding and cytotoxic activity

First launch for diclofenac gel formulation for actinic keratoses

Arius Research begins preparations for phase I clinical trials of cancer-killing antibodies

Rapid and effective control of malignancy-associated hyperuricemia achieved on rasburicase

University of Pittsburgh awarded two grants to support AIDS research

EMEA assigns orphan drug status to gene therapy for SCID-X1

Neurochem and Nycomed Amersham Imaging to develop Alzheimer's diagnostic

Y-27632 inhibits noradrenergic contractions in penile tissue

Novartis acquires certain rights to investigational diabetes drug from Novo Nordisk

Oxxon Pharmaccines licenses adenovirus vaccine technology from Isis Innovation

Discovery Partners and Maxia extend drug discovery collaboration

Gel formulations of anionic surfactants useful against sexually transmitted pathogens

MorphoSys reaches milestone in antibody collaboration with GPC Biotech

MetaPhore's M-40403 successfully completes phase I evaluation

Webcast introducing Prous Science Integrity, the first integrated drug discovery portal

Pfizer focuses significant effort on the search for selective COX-2 inhibitors

Naturally occurring estrogen-like agonist discovered by Nippon Kayaku

NPY Y5 ligands have favorable effects on eating

Hypoglycemic/hypolipidemic compounds in development at Takeda

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...